Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients
Araldi, Rodrigo Pinheiro, Prezoto, Benedito Carlos, Gonzaga, Vivian, Policiquio, Bruna, Mendes, Thais Biude, D’Amélio, Fernanda, Vigerelli, Hugo, Viana, Mariana, Valverde, Cristiane Wenceslau, Pagani, Eduardo, Kerkis, Irina
Published in Biomedicine & pharmacotherapy (01.05.2022)
Published in Biomedicine & pharmacotherapy (01.05.2022)
Get full text
Journal Article